Plastic Bronchitis in Patients With Fontan Physiology: Review of the Literature and Preliminary Experience With Fontan Conversion and Cardiac Transplantation

World Journal for Pediatric and Congenital Heart Surgery

Volumn 3, Issue 3, 2012, Pages 364-372

  Larue, Madeleine ^a   Gossett, Jeffrey G ^b   Stewart, Robert D ^c   Backer, Carl L ^b   Mavroudis, Constantine ^d   Jacobs, Marshall L ^c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d FLORIDA HOSPITAL   (United States)

Author keywords

bronchial casts; cardiac transplantation; congenital heart disease; Fontan conversion; plastic bronchitis; protein losing enteropathy; single ventricle anatomy

Indexed keywords

ACETYLCYSTEINE; CLARITHROMYCIN; FIBRIN; SALBUTAMOL;

ANNULOPLASTY; ARTERY RECONSTRUCTION; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR SEPTAL DEFECT; BLALOCK TAUSSIG SHUNT; BRONCHITIS; BRONCHOSCOPY; CASE REPORT; CAVOPULMONARY CONNECTION; CONGENITAL HEART MALFORMATION; CRYOABLATION; FEMALE; FONTAN PROCEDURE; GLENN SHUNT; GREAT VESSELS TRANSPOSITION; HEART CATHETERIZATION; HEART RIGHT VENTRICLE FAILURE; HEART SINGLE VENTRICLE; HEART TRANSPLANTATION; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; HYPOPLASTIC LEFT HEART SYNDROME; HYPOPLASTIC RIGHT VENTICLE; LUNG INFILTRATE; MALE; MITRAL VALVE STENOSIS; PATHOPHYSIOLOGY; PLASTIC BRONCHITIS; PLEURA EFFUSION; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN LOSING GASTROENTEROPATHY; PULMONARY VALVE ATRESIA; RECURRENT DISEASE; REVIEW; SICK SINUS SYNDROME;

EID: 84875461828     PISSN: 21501351     EISSN: 21500136     Source Type: Journal    
DOI: 10.1177/2150135112438107     Document Type: Review

References (69)

1. Jacobs ML Pelletier G. Late complications associated with the Fontan circulation. Cardiol Young. 2006; 16(Supplement 1):80-84.
2. Trojnarska O Cieplucha A. Challenges of management and therapy in patients with a functionally single ventricle after the Fontan operation. Cardiol J. 2011; 18(2):119-127.
3. Beghetti M. Fontan and the pulmonary circulation: a potential role for new hypertension therapies. Heart. 2010; 96(12):911-916.
4. Seear M Hui H Magee F Bohn D Cutz E. Bronchial casts in children: a proposed classification based on nine cases and a review of the literature. Am J Respir Crit Care Med. 1997; 155(1):364-370.
5. Do TB Chu JM Berdjis F Anas NG. Fontan patient with plastic bronchitis treated successfully using aerosolized tissue plasminogen activator: a case report and review of the literature. Pediatr Cardiol. 2009; 30(3):352-355.
6. Brogan TV Finn LS Pyskaty DJ, et al Plastic bronchitis in children: a case series and review of the medical literature. Pediatr Pulmonol. 2002; 34(6):482-487.
7. Ishman S Book DT Conley SF Kerschner JE. Plastic bronchitis: an unusual bronchoscopic challenge associated with congenital heart disease repair. Int J Pediatr Otorhinolaryngol. 2003; 67(5):543-548.
8. Madsen P Shah SA Rubin BK. Plastic bronchitis: new insights and a classification scheme. Paediatr Respir Rev. 2005; 6(4):292-300.
9. Languepin J Scheinmann P Mahut B, et al Bronchial casts in children with cardiomyopathies: the role of pulmonary lymphatic abnormalities. Pediatr Pulmonol. 1999; 28(5):329-336.
10. Quasney MW Orman K Thompson J, et al Plastic bronchitis occurring late after the Fontan procedure: treatment with aerosolized urokinase. Crit Care Med. 2000; 28(6):2107-2111.
11. Chaudhari M Stumper O. Plastic bronchitis after Fontan operation: treatment with stent fenestration of the Fontan circuit. Heart. 2004; 90(7):801.
12. Wilson J Russell J Williams W Benson L. Fenestration of the Fontan circuit as treatment for plastic bronchitis. Pediatr Cardiol. 2005; 26(5):717-719.
13. Yalcin E Ozcelik U Celiker A. Plastic bronchitis occurring late after the Fontan procedure in a child: treatment with stent implantation in the left pulmonary artery. J Invasive Cardiol. 2005; 17(6):326-328.
14. Barber BJ Burch GH Tripple D Balaji S. Resolution of plastic bronchitis with atrial pacing in a patient with Fontan physiology. Pediatr Cardiol. 2004; 25(1):73-76.
15. Goo HW Jhang WK Kim YH, et al CT findings of plastic bronchitis in children after a Fontan operation. Pediatr Radiol. 2008; 38(9):989-993.
16. Apostolopoulou SC Papagiannis J Rammos S. Bosentan induces clinical, exercise and hemodynamic improvement in a pre-transplant patient with plastic bronchitis after Fontan operation. J Heart Lung Transplant. 2005; 24(8):1174-1176.
17. McMahon CJ Nihill MR Reber A. The bronchial cast syndrome after the Fontan procedure: further evidence of its etiology. Cardiol Young. 2001; 11(3):345-351.
18. Shah SSA Drinkwater DC Christian KG. Plastic bronchitis: is thoracic duct ligation a real surgical option? Ann Thorac Surg. 2006; 81(6):2281-2283.
19. Nayar S Parmar R Kulkarni S Cherian KM. Treatment of plastic bronchitis. Ann Thorac Surg. 2007; 83(5):1884-1886.
20. Feldt RH Driscoll DJ Offord KP, et al Protein-losing enteropathy after the Fontan operation. J Thorac Cardiovasc Surg. 1996; 112(3):672-680.
21. Goldberg DJ Dodds K Rychik J. Rare problems associated with the Fontan circulation. Cardiol Young. 2010; 20(Supplement 3):113-119.
22. Hess J Kruizinga K Bijleveld MA Hardjowijono R Eygelaar A. Protein-losing enteropathy after Fontan operation. J Thorac Cardiovasc Surg. 1984; 88(4):606-609.
23. Murch SH Winyard PJD Koletzko S, et al Congenital enterocyte heparan sulfate deficiency with massive albumin loss, secretory diarrhea, and malnutrition. Lancet. 1996; 347(9011):1299-1301.
24. Papakonstantinou E Karakiulakis G. The sweet and bitter involvement of glycosaminoglycans in lung diseases: pharmacotherapeutic relevance. Br J Pharmacol. 2009; 157(7):1111-1127.
25. Donnelly JP Rosenthal A Castle VP Holmes RD. Reversal of protein-losing enteropathy with heparin therapy in three patients with univentricular hearts and Fontan palliation. J Pediatr. 1997; 130(3):474-478.
26. Westphal V Murch S Kim S, et al Reduced heparan sulfate accumulation in enterocytes contributes to protein-losing enteropathy in a congenital disorder of glycosylation. Am J Pathol. 2000; 157(6):1917-1925.
27. Murch S Salvestrini C Myrdal U, et al Focal loss of duodenal enterocyte heparan sulfate proteoglycans may contribute to protein-losing enteropathy after Fontan surgery. World Congress of Pediatric Gastroenterology, Hepatology and Nutrition: Paris, France. J Pediatr Gastroenterol Nutr. 2004; 39: S278-S279.
28. Lenz D Hambsch J Schneider P, et al Protein-losing enteropathy in patients with Fontan circulation: is it triggered by infection? Crit Care. 2003; 7(2):185-190.
29. Shimizu T Nagata S Fujii T, et al Enhanced production of interferon-gamma as a possible cause of protein-losing enteropathy after modified Fontan operation. J Pediatr Gastroenterol Nutr. 2003; 37(4):504-507.
30. Ostrow AM Freeze H Rychik J. Protein-losing enteropathy after Fontan operation: investigations into possible pathophysiologic mechanisms. Ann Thorac Surg. 2006; 82(2):695-700.
31. Schmitz H Fromm M Bentzel CJ, et al Tumor necrosis factor alpha regulates the epithelial barrier in the human intestinal cell line HT-29/B6. J Cell Sci. 1999; 112(pt 1):137-146.
32. Madara JL Stafford J. Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers. J Clin Invest. 1989; 83(2):724-727.
33. Fish SM Proujansky R Reenstra WW. Synergistic effects of interferon gamma and tumor necrosis factor alpha on T84 cell function. Gut. 1999; 45(4):191-198.
34. Bode L Murch S Freeze H. Heparan sulfate plays a central role in a dynamic in vitro model of protein-losing enteropathy. J Biol Chem. 2006; 281(12):7809-7815.
35. Bode L Salvestrini C Park PW, et al Haparan sulfate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier function. J Clin Invest. 2008; 118(1):229-238.
36. Smits NC Shworak NW Dekhuijzen PN van Kuppevelt TH. Heparan sulfates in the lung: structure, diversity, and role in pulmonary emphysema. Anat Rec (Hoboken). 2010; 293(6):955-967.
37. Xu J Park PW Kheradmand F Corry DB. Endogenous attenuation of allergic lung inflammation by syndecan-1. J Immunol. 2005; 174(9):5758-5765.
38. Kanwar YS Linker A Farquhar MG. Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparan sulfate) by enzyme digestion. J Cell Biol. 1980; 86(2):688-693.
39. Mazzon E Cuzzocrea S. Role of TNF-alpha in lung tight junction alteration in mouse model of acute lung inflammation. Respir Res. 2007; 8: 75.
40. Costello JM Steinhorn D McColley S Gerber ME Kumar SP. Treatment of plastic bronchitis in a Fontan patient with tissue plasminogen activator: a case report and review of the literature. Pediatrics. 2002; 109(4):e67.
41. Haseyama K Satomi G Yasukochi S, et al Pulmonary vasodilation therapy with sildenafil citrate in a patient with plastic bronchitis after the Fontan procedure for hypoplastic left heart syndrome. J Thorac Cardiovasc Surg. 2006; 132(5):1232-1233.
42. Stiller B Riedel F Paul K van Landeghem FKH. Plastic bronchitis in children with Fontan palliation: analogue to protein-losing enteropathy? Pediatr Cardiol. 2002; 23(1):90-94.
43. Onoue Y Adachi Y Ichida F Miyawaki T. Effective use of corticosteroid in a child with life-threatening plastic bronchitis after Fontan operation. Pediatr Int. 2003; 45(1):107-109.
44. Mendoza Soto A Galletti L Gomez de Quero P Ramos Casado MV Velasco Bayon JM. Plastic bronchitis: a case report and review of the literature. An Pediatr (Barc). 2005; 62(1):72-75.
45. El Mallah MK Prabhakaran S Chesrown S. Plastic bronchitis: resolution after heart transplantation. Pediatr Pulmonol. 2011; 46(8):824-825.
46. Laubisch JE Green DM Mogayzel PJ Thompson WR. Treatment of plastic bronchitis by orthotopic heart transplantation. Pediatr Cardiol. 2011; 32(8):1193-1195.
47. Bendayan I Casaldaliga J Castello F Miro L. Herparin therapy and reversal of protein-losing enteropathy in a case with congenital heart disease. Pediatr Cardiol. 2000; 21(3):267-268.
48. Lortat-Jacob H Grimaud JA. Interferon-gamma binds to heparan sulfate by a cluster of amino acids located in the C-terminal part of the molecule. FEBS Lett. 1991; 280(1):152-154.
49. Lortat-Jacob H Grimaud JA. Interferon-gamma C-terminal function: new working hypothesis. Heparan sulfate and heparin, new targets for IFN-gamma, protect, relax the cytokine and regulate its activity. Cell Mol Biol. 1991; 37(3):253-260.
50. Harvima IT Lappalainen K Hirvonen MR, et al Heparin modulates the growth and adherence and augments the growth-inhibitory action of TNF-alpha on cultured human keratinocytes. J Cell Biochem. 2004; 92(2):372-386.
51. Rychik J Piccoli DA Barber G. Usefulness of corticosteroid therapy for protein-losing enteropathy after the Fontan procedure. Am J Cardiol. 1991; 68(8):819-821.
52. Zellers TM Brown K. Protein-losing enteropathy after the modified Fontan operation: oral prednisone treatment with biopsy and laboratory proved improvement. Pediatr Cardiol. 1996; 17(2):115-117.
53. Thacker D Patel A Dodds K, et al Use of oral budesonide in the management of protein-losing enteropathy after the Fontan operation. Ann Thorac Surg. 2010; 89(3):837-842.
54. Schumacher KR Cools M Goldstein BH, et al Oral budesonide treatment for protein-losing enteropathy in Fontan-palliated patients. Pediatr Cardiol. 2011; 32(7):966-971.
55. Mertens L Hagler DJ Sauer U Somerville J Gewillig M. Protein-losing enteropathy after the Fontan operation: an international multicenter study. J Thorac Cardiovasc Surg. 1998; 115(5):1063-1073.
56. Meadows J Jenkins K. Protein-losing enteropathy: integrating a new disease paradigm into recommendations for prevention and treatment. Cardiol Young. 2011; 21(4):363-377.
57. Cohen MI Rhodes LA Wernovsky G, et al Atrial pacing: an alternative treatment for protein-losing enteropathy after the Fontan operation. J Thorac Cardiovasc Surg. 2001; 121(3):582-583.
58. Vyas H Driscoll DJ Cabalka AK Cetta F Hagler DJ. Results of transcatheter Fontan fenestration to treat protein losing enteropathy. Catheter Cardiovasc Interv. 2007; 69(4):584-589.
59. Rychik J Rome JJ Jacobs ML. Late surgical fenestration for complications after the Fontan operation. Circulation. 1997; 96(1):33-36.
60. Jacobs ML Rychik J Byrum CJ Norwood WI. Protein-losing enteropathy after Fontan operation: resolution after baffle fenestration. Ann Thorac Surg. 1996; 61(1):206-208.
61. Mavroudis C Deal BJ, Backer CL, et al. 111 Fontan conversions with arrhythmia surgery: surgical lessons and outcomes. Ann Thorac Surg. 2007; 84(5):1457-1466.
62. Weinstein S Chan D. Extracardiac Fontan conversion, cryoablation, and pacemaker placement for patients with a failed Fontan. Semin Thorac Cardiovasc Surg. 2005; 17(2):170-178.
63. Marcelletti CF Hanley FL Mavroudis C, et al Revision of previous Fontan connections to total extracardiac cavopulmonary anastomosis: a multicenter experience. J Thorac Cardiovasc Surg. 2000; 119(2):340-346.
64. Mitchell MB Campbell DN Boucek MM. Heart transplantation for the failing Fontan circulation. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2004; 7: 56-64.
65. Gamba A Merlo M Fiocchi R, et al Heart transplantation in patients with previous Fontan operations. J Thorac Cardiovasc Surg. 2004; 127(2):555-562.
66. Bernstein D Naftel D Chin C, et al Outcome of listing for cardiac transplantation for failed Fontan: a multi-institutional study. Circulation. 2006; 114(4):273-280.
67. Kanter KR Mahle WT Vincent RN, et al Heart transplantation in children with a Fontan procedure. Ann Thorac Surg. 2011; 91(3):823-830.
68. Lamour JM Addonizio LJ Galantowicz ME, et al. Outcome after orthotopic cardiac transplantation in adults with congenital heart disease. Circulation. 1999: 100(19 Supplement):II-200-II-205.
69. Brancaccio G Carotti A D’Argenio P Michielon G Parisi F. Protein-losing enteropathy after Fontan surgery: resolution after cardiac transplantation. J Heart Lung Transplant. 2003; 22(4):484-486.